PLOS ONE:雄激素受体阳性的三阴乳腺癌:临床病理,预后和预测特征

2018-06-10 海北 MedSci原创

雄激素受体(AR)的过表达表征三阴性乳腺癌(TNBC)的独特分子亚群。 AR作为TNBC中预后/预测性生物标志物的作用是有争议的,但越来越多的证据表明该亚型可能对靶向AR的治疗剂有反应。

雄激素受体(AR)的过表达表征三阴性乳腺癌TNBC)的独特分子亚群。 AR作为TNBC中预后/预测性生物标志物的作用是有争议的,但越来越多的证据表明该亚型可能对靶向AR的治疗剂有反应。

AR的评估尚未标准化,如何选择接受抗雄激素疗法的患者仍然存在争议。在最近的一项研究中,研究人员确定AR免疫反应性的适当阈值,以定义AR阳性(AR +TNBC,描述了AR + TNBC临床病理学特征,并讨论AR阳性作为TNBC中预后和预测标记的效用。

根据ASCO / CAP指南,研究人员处理了135例侵入性TNBC,对AR进行免疫染色。分析AR + TNBC临床病理特征,并与AR阴性(AR-TNBC比较。研究人员也统计评估了患者的年龄,肿瘤大小,肿瘤分级,淋巴结状态,增殖率,EGFR免疫阳性,CK5 / 6Ki-67和无病生存率(DFS)。

研究人员将1%的切点确定为AR阳性的适当阈值。使用这个切点,135TNBC中有41%是AR + AR + TNBC发生于老年女性,比AR-TNBC更大,平均增殖率更低,腋窝转移发生率更高。具有顶泌形态的TNBC中,76%是AR +。一部分AR + TNBC表达基础标志物(EGFRCK5 / 6)。预测模型已创建。

因此,AR确定了TNBC的异质组。EGFR表达的额外评估使研究人员能够将TNBC分层为3个风险组,在DFS和治疗意义上存在显着差异:代表LAR分子亚型的低风险组(AR + EGFR-),具有最佳预后并且可能最大程度受益于抗雄激素治疗; 高风险组(AR-EGFR +),代表预后最差的基础分子亚型,并且可能从化疗方案中获益最多; 中等预后风险组(AR + EGFR +AR-EGFR-)。需要进行前瞻性试验以进一步验证这种预后和预测分组。


原始出处:
Astvatsaturyan K et al. Androgen receptor positive triple negative breast cancer: Clinicopathologic, prognostic, and predictive features. PLOS ONE, 2018; DOI: 10.1371/journal.pone.0197827

本文系梅斯医学(MedSci)原创编译整理,转载需授权! 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (21)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1980851, encodeId=39791980851dd, content=<a href='/topic/show?id=aaf6668192d' target=_blank style='color:#2F92EE;'>#激素受体阳性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66819, encryptionId=aaf6668192d, topicName=激素受体阳性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5662228, createdName=mjldent, createdTime=Sun Apr 14 21:14:00 CST 2019, time=2019-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797469, encodeId=2fb41e9746945, content=<a href='/topic/show?id=96eb22906b9' target=_blank style='color:#2F92EE;'>#临床病理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22906, encryptionId=96eb22906b9, topicName=临床病理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Sun Oct 14 06:14:00 CST 2018, time=2018-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1790221, encodeId=48ec1e9022142, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Sat Jun 16 22:14:00 CST 2018, time=2018-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327106, encodeId=671732e10696, content=和某大型骨干 v 巴基耶夫的现身说法有太多, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/05/ed2bf06fea1e697cb8fe1644bfcec307.jpg, createdBy=73971617491, createdName=小小医森, createdTime=Tue Jun 26 08:39:15 CST 2018, time=2018-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326832, encodeId=3de7326832cf, content=感谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/05/ed2bf06fea1e697cb8fe1644bfcec307.jpg, createdBy=73971617491, createdName=小小医森, createdTime=Mon Jun 25 08:07:54 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326597, encodeId=a7e732659efe, content=哈哈哈哈哈哈哈哈好, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/05/ed2bf06fea1e697cb8fe1644bfcec307.jpg, createdBy=73971617491, createdName=小小医森, createdTime=Sun Jun 24 10:50:31 CST 2018, time=2018-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=324342, encodeId=b9ee32434256, content=感谢学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/05/ed2bf06fea1e697cb8fe1644bfcec307.jpg, createdBy=73971617491, createdName=小小医森, createdTime=Fri Jun 15 07:58:18 CST 2018, time=2018-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323993, encodeId=095b323993ab, content=学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzR8ylhYfiaoAUx2BsaYHVia1IKhG3Cg8CT84rBrn6iaVRkyAibJxBcLEXabOQ5p19vWgDe34ib5ErxNgx/0, createdBy=8a701629084, createdName=jihuaijun1112, createdTime=Thu Jun 14 06:32:02 CST 2018, time=2018-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323988, encodeId=d56132398843, content=哈哈哈哈哈哈哈哈好, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/05/ed2bf06fea1e697cb8fe1644bfcec307.jpg, createdBy=73971617491, createdName=小小医森, createdTime=Thu Jun 14 06:27:31 CST 2018, time=2018-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323786, encodeId=6aa4323e86d7, content=学习学习学习创新宣传促销, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/05/ed2bf06fea1e697cb8fe1644bfcec307.jpg, createdBy=73971617491, createdName=小小医森, createdTime=Wed Jun 13 08:12:22 CST 2018, time=2018-06-13, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1980851, encodeId=39791980851dd, content=<a href='/topic/show?id=aaf6668192d' target=_blank style='color:#2F92EE;'>#激素受体阳性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66819, encryptionId=aaf6668192d, topicName=激素受体阳性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5662228, createdName=mjldent, createdTime=Sun Apr 14 21:14:00 CST 2019, time=2019-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797469, encodeId=2fb41e9746945, content=<a href='/topic/show?id=96eb22906b9' target=_blank style='color:#2F92EE;'>#临床病理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22906, encryptionId=96eb22906b9, topicName=临床病理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Sun Oct 14 06:14:00 CST 2018, time=2018-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1790221, encodeId=48ec1e9022142, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Sat Jun 16 22:14:00 CST 2018, time=2018-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327106, encodeId=671732e10696, content=和某大型骨干 v 巴基耶夫的现身说法有太多, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/05/ed2bf06fea1e697cb8fe1644bfcec307.jpg, createdBy=73971617491, createdName=小小医森, createdTime=Tue Jun 26 08:39:15 CST 2018, time=2018-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326832, encodeId=3de7326832cf, content=感谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/05/ed2bf06fea1e697cb8fe1644bfcec307.jpg, createdBy=73971617491, createdName=小小医森, createdTime=Mon Jun 25 08:07:54 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326597, encodeId=a7e732659efe, content=哈哈哈哈哈哈哈哈好, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/05/ed2bf06fea1e697cb8fe1644bfcec307.jpg, createdBy=73971617491, createdName=小小医森, createdTime=Sun Jun 24 10:50:31 CST 2018, time=2018-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=324342, encodeId=b9ee32434256, content=感谢学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/05/ed2bf06fea1e697cb8fe1644bfcec307.jpg, createdBy=73971617491, createdName=小小医森, createdTime=Fri Jun 15 07:58:18 CST 2018, time=2018-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323993, encodeId=095b323993ab, content=学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzR8ylhYfiaoAUx2BsaYHVia1IKhG3Cg8CT84rBrn6iaVRkyAibJxBcLEXabOQ5p19vWgDe34ib5ErxNgx/0, createdBy=8a701629084, createdName=jihuaijun1112, createdTime=Thu Jun 14 06:32:02 CST 2018, time=2018-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323988, encodeId=d56132398843, content=哈哈哈哈哈哈哈哈好, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/05/ed2bf06fea1e697cb8fe1644bfcec307.jpg, createdBy=73971617491, createdName=小小医森, createdTime=Thu Jun 14 06:27:31 CST 2018, time=2018-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323786, encodeId=6aa4323e86d7, content=学习学习学习创新宣传促销, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/05/ed2bf06fea1e697cb8fe1644bfcec307.jpg, createdBy=73971617491, createdName=小小医森, createdTime=Wed Jun 13 08:12:22 CST 2018, time=2018-06-13, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1980851, encodeId=39791980851dd, content=<a href='/topic/show?id=aaf6668192d' target=_blank style='color:#2F92EE;'>#激素受体阳性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66819, encryptionId=aaf6668192d, topicName=激素受体阳性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5662228, createdName=mjldent, createdTime=Sun Apr 14 21:14:00 CST 2019, time=2019-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797469, encodeId=2fb41e9746945, content=<a href='/topic/show?id=96eb22906b9' target=_blank style='color:#2F92EE;'>#临床病理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22906, encryptionId=96eb22906b9, topicName=临床病理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Sun Oct 14 06:14:00 CST 2018, time=2018-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1790221, encodeId=48ec1e9022142, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Sat Jun 16 22:14:00 CST 2018, time=2018-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327106, encodeId=671732e10696, content=和某大型骨干 v 巴基耶夫的现身说法有太多, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/05/ed2bf06fea1e697cb8fe1644bfcec307.jpg, createdBy=73971617491, createdName=小小医森, createdTime=Tue Jun 26 08:39:15 CST 2018, time=2018-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326832, encodeId=3de7326832cf, content=感谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/05/ed2bf06fea1e697cb8fe1644bfcec307.jpg, createdBy=73971617491, createdName=小小医森, createdTime=Mon Jun 25 08:07:54 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326597, encodeId=a7e732659efe, content=哈哈哈哈哈哈哈哈好, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/05/ed2bf06fea1e697cb8fe1644bfcec307.jpg, createdBy=73971617491, createdName=小小医森, createdTime=Sun Jun 24 10:50:31 CST 2018, time=2018-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=324342, encodeId=b9ee32434256, content=感谢学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/05/ed2bf06fea1e697cb8fe1644bfcec307.jpg, createdBy=73971617491, createdName=小小医森, createdTime=Fri Jun 15 07:58:18 CST 2018, time=2018-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323993, encodeId=095b323993ab, content=学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzR8ylhYfiaoAUx2BsaYHVia1IKhG3Cg8CT84rBrn6iaVRkyAibJxBcLEXabOQ5p19vWgDe34ib5ErxNgx/0, createdBy=8a701629084, createdName=jihuaijun1112, createdTime=Thu Jun 14 06:32:02 CST 2018, time=2018-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323988, encodeId=d56132398843, content=哈哈哈哈哈哈哈哈好, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/05/ed2bf06fea1e697cb8fe1644bfcec307.jpg, createdBy=73971617491, createdName=小小医森, createdTime=Thu Jun 14 06:27:31 CST 2018, time=2018-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323786, encodeId=6aa4323e86d7, content=学习学习学习创新宣传促销, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/05/ed2bf06fea1e697cb8fe1644bfcec307.jpg, createdBy=73971617491, createdName=小小医森, createdTime=Wed Jun 13 08:12:22 CST 2018, time=2018-06-13, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1980851, encodeId=39791980851dd, content=<a href='/topic/show?id=aaf6668192d' target=_blank style='color:#2F92EE;'>#激素受体阳性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66819, encryptionId=aaf6668192d, topicName=激素受体阳性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5662228, createdName=mjldent, createdTime=Sun Apr 14 21:14:00 CST 2019, time=2019-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797469, encodeId=2fb41e9746945, content=<a href='/topic/show?id=96eb22906b9' target=_blank style='color:#2F92EE;'>#临床病理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22906, encryptionId=96eb22906b9, topicName=临床病理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Sun Oct 14 06:14:00 CST 2018, time=2018-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1790221, encodeId=48ec1e9022142, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Sat Jun 16 22:14:00 CST 2018, time=2018-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327106, encodeId=671732e10696, content=和某大型骨干 v 巴基耶夫的现身说法有太多, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/05/ed2bf06fea1e697cb8fe1644bfcec307.jpg, createdBy=73971617491, createdName=小小医森, createdTime=Tue Jun 26 08:39:15 CST 2018, time=2018-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326832, encodeId=3de7326832cf, content=感谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/05/ed2bf06fea1e697cb8fe1644bfcec307.jpg, createdBy=73971617491, createdName=小小医森, createdTime=Mon Jun 25 08:07:54 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326597, encodeId=a7e732659efe, content=哈哈哈哈哈哈哈哈好, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/05/ed2bf06fea1e697cb8fe1644bfcec307.jpg, createdBy=73971617491, createdName=小小医森, createdTime=Sun Jun 24 10:50:31 CST 2018, time=2018-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=324342, encodeId=b9ee32434256, content=感谢学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/05/ed2bf06fea1e697cb8fe1644bfcec307.jpg, createdBy=73971617491, createdName=小小医森, createdTime=Fri Jun 15 07:58:18 CST 2018, time=2018-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323993, encodeId=095b323993ab, content=学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzR8ylhYfiaoAUx2BsaYHVia1IKhG3Cg8CT84rBrn6iaVRkyAibJxBcLEXabOQ5p19vWgDe34ib5ErxNgx/0, createdBy=8a701629084, createdName=jihuaijun1112, createdTime=Thu Jun 14 06:32:02 CST 2018, time=2018-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323988, encodeId=d56132398843, content=哈哈哈哈哈哈哈哈好, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/05/ed2bf06fea1e697cb8fe1644bfcec307.jpg, createdBy=73971617491, createdName=小小医森, createdTime=Thu Jun 14 06:27:31 CST 2018, time=2018-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323786, encodeId=6aa4323e86d7, content=学习学习学习创新宣传促销, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/05/ed2bf06fea1e697cb8fe1644bfcec307.jpg, createdBy=73971617491, createdName=小小医森, createdTime=Wed Jun 13 08:12:22 CST 2018, time=2018-06-13, status=1, ipAttribution=)]
    2018-06-26 小小医森

    和某大型骨干 v 巴基耶夫的现身说法有太多

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1980851, encodeId=39791980851dd, content=<a href='/topic/show?id=aaf6668192d' target=_blank style='color:#2F92EE;'>#激素受体阳性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66819, encryptionId=aaf6668192d, topicName=激素受体阳性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5662228, createdName=mjldent, createdTime=Sun Apr 14 21:14:00 CST 2019, time=2019-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797469, encodeId=2fb41e9746945, content=<a href='/topic/show?id=96eb22906b9' target=_blank style='color:#2F92EE;'>#临床病理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22906, encryptionId=96eb22906b9, topicName=临床病理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Sun Oct 14 06:14:00 CST 2018, time=2018-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1790221, encodeId=48ec1e9022142, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Sat Jun 16 22:14:00 CST 2018, time=2018-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327106, encodeId=671732e10696, content=和某大型骨干 v 巴基耶夫的现身说法有太多, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/05/ed2bf06fea1e697cb8fe1644bfcec307.jpg, createdBy=73971617491, createdName=小小医森, createdTime=Tue Jun 26 08:39:15 CST 2018, time=2018-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326832, encodeId=3de7326832cf, content=感谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/05/ed2bf06fea1e697cb8fe1644bfcec307.jpg, createdBy=73971617491, createdName=小小医森, createdTime=Mon Jun 25 08:07:54 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326597, encodeId=a7e732659efe, content=哈哈哈哈哈哈哈哈好, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/05/ed2bf06fea1e697cb8fe1644bfcec307.jpg, createdBy=73971617491, createdName=小小医森, createdTime=Sun Jun 24 10:50:31 CST 2018, time=2018-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=324342, encodeId=b9ee32434256, content=感谢学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/05/ed2bf06fea1e697cb8fe1644bfcec307.jpg, createdBy=73971617491, createdName=小小医森, createdTime=Fri Jun 15 07:58:18 CST 2018, time=2018-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323993, encodeId=095b323993ab, content=学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzR8ylhYfiaoAUx2BsaYHVia1IKhG3Cg8CT84rBrn6iaVRkyAibJxBcLEXabOQ5p19vWgDe34ib5ErxNgx/0, createdBy=8a701629084, createdName=jihuaijun1112, createdTime=Thu Jun 14 06:32:02 CST 2018, time=2018-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323988, encodeId=d56132398843, content=哈哈哈哈哈哈哈哈好, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/05/ed2bf06fea1e697cb8fe1644bfcec307.jpg, createdBy=73971617491, createdName=小小医森, createdTime=Thu Jun 14 06:27:31 CST 2018, time=2018-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323786, encodeId=6aa4323e86d7, content=学习学习学习创新宣传促销, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/05/ed2bf06fea1e697cb8fe1644bfcec307.jpg, createdBy=73971617491, createdName=小小医森, createdTime=Wed Jun 13 08:12:22 CST 2018, time=2018-06-13, status=1, ipAttribution=)]
    2018-06-25 小小医森

    感谢分享.学习了

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1980851, encodeId=39791980851dd, content=<a href='/topic/show?id=aaf6668192d' target=_blank style='color:#2F92EE;'>#激素受体阳性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66819, encryptionId=aaf6668192d, topicName=激素受体阳性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5662228, createdName=mjldent, createdTime=Sun Apr 14 21:14:00 CST 2019, time=2019-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797469, encodeId=2fb41e9746945, content=<a href='/topic/show?id=96eb22906b9' target=_blank style='color:#2F92EE;'>#临床病理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22906, encryptionId=96eb22906b9, topicName=临床病理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Sun Oct 14 06:14:00 CST 2018, time=2018-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1790221, encodeId=48ec1e9022142, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Sat Jun 16 22:14:00 CST 2018, time=2018-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327106, encodeId=671732e10696, content=和某大型骨干 v 巴基耶夫的现身说法有太多, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/05/ed2bf06fea1e697cb8fe1644bfcec307.jpg, createdBy=73971617491, createdName=小小医森, createdTime=Tue Jun 26 08:39:15 CST 2018, time=2018-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326832, encodeId=3de7326832cf, content=感谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/05/ed2bf06fea1e697cb8fe1644bfcec307.jpg, createdBy=73971617491, createdName=小小医森, createdTime=Mon Jun 25 08:07:54 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326597, encodeId=a7e732659efe, content=哈哈哈哈哈哈哈哈好, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/05/ed2bf06fea1e697cb8fe1644bfcec307.jpg, createdBy=73971617491, createdName=小小医森, createdTime=Sun Jun 24 10:50:31 CST 2018, time=2018-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=324342, encodeId=b9ee32434256, content=感谢学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/05/ed2bf06fea1e697cb8fe1644bfcec307.jpg, createdBy=73971617491, createdName=小小医森, createdTime=Fri Jun 15 07:58:18 CST 2018, time=2018-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323993, encodeId=095b323993ab, content=学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzR8ylhYfiaoAUx2BsaYHVia1IKhG3Cg8CT84rBrn6iaVRkyAibJxBcLEXabOQ5p19vWgDe34ib5ErxNgx/0, createdBy=8a701629084, createdName=jihuaijun1112, createdTime=Thu Jun 14 06:32:02 CST 2018, time=2018-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323988, encodeId=d56132398843, content=哈哈哈哈哈哈哈哈好, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/05/ed2bf06fea1e697cb8fe1644bfcec307.jpg, createdBy=73971617491, createdName=小小医森, createdTime=Thu Jun 14 06:27:31 CST 2018, time=2018-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323786, encodeId=6aa4323e86d7, content=学习学习学习创新宣传促销, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/05/ed2bf06fea1e697cb8fe1644bfcec307.jpg, createdBy=73971617491, createdName=小小医森, createdTime=Wed Jun 13 08:12:22 CST 2018, time=2018-06-13, status=1, ipAttribution=)]
    2018-06-24 小小医森

    哈哈哈哈哈哈哈哈好

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1980851, encodeId=39791980851dd, content=<a href='/topic/show?id=aaf6668192d' target=_blank style='color:#2F92EE;'>#激素受体阳性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66819, encryptionId=aaf6668192d, topicName=激素受体阳性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5662228, createdName=mjldent, createdTime=Sun Apr 14 21:14:00 CST 2019, time=2019-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797469, encodeId=2fb41e9746945, content=<a href='/topic/show?id=96eb22906b9' target=_blank style='color:#2F92EE;'>#临床病理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22906, encryptionId=96eb22906b9, topicName=临床病理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Sun Oct 14 06:14:00 CST 2018, time=2018-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1790221, encodeId=48ec1e9022142, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Sat Jun 16 22:14:00 CST 2018, time=2018-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327106, encodeId=671732e10696, content=和某大型骨干 v 巴基耶夫的现身说法有太多, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/05/ed2bf06fea1e697cb8fe1644bfcec307.jpg, createdBy=73971617491, createdName=小小医森, createdTime=Tue Jun 26 08:39:15 CST 2018, time=2018-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326832, encodeId=3de7326832cf, content=感谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/05/ed2bf06fea1e697cb8fe1644bfcec307.jpg, createdBy=73971617491, createdName=小小医森, createdTime=Mon Jun 25 08:07:54 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326597, encodeId=a7e732659efe, content=哈哈哈哈哈哈哈哈好, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/05/ed2bf06fea1e697cb8fe1644bfcec307.jpg, createdBy=73971617491, createdName=小小医森, createdTime=Sun Jun 24 10:50:31 CST 2018, time=2018-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=324342, encodeId=b9ee32434256, content=感谢学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/05/ed2bf06fea1e697cb8fe1644bfcec307.jpg, createdBy=73971617491, createdName=小小医森, createdTime=Fri Jun 15 07:58:18 CST 2018, time=2018-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323993, encodeId=095b323993ab, content=学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzR8ylhYfiaoAUx2BsaYHVia1IKhG3Cg8CT84rBrn6iaVRkyAibJxBcLEXabOQ5p19vWgDe34ib5ErxNgx/0, createdBy=8a701629084, createdName=jihuaijun1112, createdTime=Thu Jun 14 06:32:02 CST 2018, time=2018-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323988, encodeId=d56132398843, content=哈哈哈哈哈哈哈哈好, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/05/ed2bf06fea1e697cb8fe1644bfcec307.jpg, createdBy=73971617491, createdName=小小医森, createdTime=Thu Jun 14 06:27:31 CST 2018, time=2018-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323786, encodeId=6aa4323e86d7, content=学习学习学习创新宣传促销, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/05/ed2bf06fea1e697cb8fe1644bfcec307.jpg, createdBy=73971617491, createdName=小小医森, createdTime=Wed Jun 13 08:12:22 CST 2018, time=2018-06-13, status=1, ipAttribution=)]
    2018-06-15 小小医森

    感谢学习了

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1980851, encodeId=39791980851dd, content=<a href='/topic/show?id=aaf6668192d' target=_blank style='color:#2F92EE;'>#激素受体阳性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66819, encryptionId=aaf6668192d, topicName=激素受体阳性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5662228, createdName=mjldent, createdTime=Sun Apr 14 21:14:00 CST 2019, time=2019-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797469, encodeId=2fb41e9746945, content=<a href='/topic/show?id=96eb22906b9' target=_blank style='color:#2F92EE;'>#临床病理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22906, encryptionId=96eb22906b9, topicName=临床病理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Sun Oct 14 06:14:00 CST 2018, time=2018-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1790221, encodeId=48ec1e9022142, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Sat Jun 16 22:14:00 CST 2018, time=2018-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327106, encodeId=671732e10696, content=和某大型骨干 v 巴基耶夫的现身说法有太多, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/05/ed2bf06fea1e697cb8fe1644bfcec307.jpg, createdBy=73971617491, createdName=小小医森, createdTime=Tue Jun 26 08:39:15 CST 2018, time=2018-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326832, encodeId=3de7326832cf, content=感谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/05/ed2bf06fea1e697cb8fe1644bfcec307.jpg, createdBy=73971617491, createdName=小小医森, createdTime=Mon Jun 25 08:07:54 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326597, encodeId=a7e732659efe, content=哈哈哈哈哈哈哈哈好, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/05/ed2bf06fea1e697cb8fe1644bfcec307.jpg, createdBy=73971617491, createdName=小小医森, createdTime=Sun Jun 24 10:50:31 CST 2018, time=2018-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=324342, encodeId=b9ee32434256, content=感谢学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/05/ed2bf06fea1e697cb8fe1644bfcec307.jpg, createdBy=73971617491, createdName=小小医森, createdTime=Fri Jun 15 07:58:18 CST 2018, time=2018-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323993, encodeId=095b323993ab, content=学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzR8ylhYfiaoAUx2BsaYHVia1IKhG3Cg8CT84rBrn6iaVRkyAibJxBcLEXabOQ5p19vWgDe34ib5ErxNgx/0, createdBy=8a701629084, createdName=jihuaijun1112, createdTime=Thu Jun 14 06:32:02 CST 2018, time=2018-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323988, encodeId=d56132398843, content=哈哈哈哈哈哈哈哈好, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/05/ed2bf06fea1e697cb8fe1644bfcec307.jpg, createdBy=73971617491, createdName=小小医森, createdTime=Thu Jun 14 06:27:31 CST 2018, time=2018-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323786, encodeId=6aa4323e86d7, content=学习学习学习创新宣传促销, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/05/ed2bf06fea1e697cb8fe1644bfcec307.jpg, createdBy=73971617491, createdName=小小医森, createdTime=Wed Jun 13 08:12:22 CST 2018, time=2018-06-13, status=1, ipAttribution=)]
    2018-06-14 jihuaijun1112

    学习学习学习

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1980851, encodeId=39791980851dd, content=<a href='/topic/show?id=aaf6668192d' target=_blank style='color:#2F92EE;'>#激素受体阳性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66819, encryptionId=aaf6668192d, topicName=激素受体阳性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5662228, createdName=mjldent, createdTime=Sun Apr 14 21:14:00 CST 2019, time=2019-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797469, encodeId=2fb41e9746945, content=<a href='/topic/show?id=96eb22906b9' target=_blank style='color:#2F92EE;'>#临床病理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22906, encryptionId=96eb22906b9, topicName=临床病理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Sun Oct 14 06:14:00 CST 2018, time=2018-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1790221, encodeId=48ec1e9022142, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Sat Jun 16 22:14:00 CST 2018, time=2018-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327106, encodeId=671732e10696, content=和某大型骨干 v 巴基耶夫的现身说法有太多, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/05/ed2bf06fea1e697cb8fe1644bfcec307.jpg, createdBy=73971617491, createdName=小小医森, createdTime=Tue Jun 26 08:39:15 CST 2018, time=2018-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326832, encodeId=3de7326832cf, content=感谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/05/ed2bf06fea1e697cb8fe1644bfcec307.jpg, createdBy=73971617491, createdName=小小医森, createdTime=Mon Jun 25 08:07:54 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326597, encodeId=a7e732659efe, content=哈哈哈哈哈哈哈哈好, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/05/ed2bf06fea1e697cb8fe1644bfcec307.jpg, createdBy=73971617491, createdName=小小医森, createdTime=Sun Jun 24 10:50:31 CST 2018, time=2018-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=324342, encodeId=b9ee32434256, content=感谢学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/05/ed2bf06fea1e697cb8fe1644bfcec307.jpg, createdBy=73971617491, createdName=小小医森, createdTime=Fri Jun 15 07:58:18 CST 2018, time=2018-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323993, encodeId=095b323993ab, content=学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzR8ylhYfiaoAUx2BsaYHVia1IKhG3Cg8CT84rBrn6iaVRkyAibJxBcLEXabOQ5p19vWgDe34ib5ErxNgx/0, createdBy=8a701629084, createdName=jihuaijun1112, createdTime=Thu Jun 14 06:32:02 CST 2018, time=2018-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323988, encodeId=d56132398843, content=哈哈哈哈哈哈哈哈好, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/05/ed2bf06fea1e697cb8fe1644bfcec307.jpg, createdBy=73971617491, createdName=小小医森, createdTime=Thu Jun 14 06:27:31 CST 2018, time=2018-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323786, encodeId=6aa4323e86d7, content=学习学习学习创新宣传促销, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/05/ed2bf06fea1e697cb8fe1644bfcec307.jpg, createdBy=73971617491, createdName=小小医森, createdTime=Wed Jun 13 08:12:22 CST 2018, time=2018-06-13, status=1, ipAttribution=)]
    2018-06-14 小小医森

    哈哈哈哈哈哈哈哈好

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1980851, encodeId=39791980851dd, content=<a href='/topic/show?id=aaf6668192d' target=_blank style='color:#2F92EE;'>#激素受体阳性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66819, encryptionId=aaf6668192d, topicName=激素受体阳性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5662228, createdName=mjldent, createdTime=Sun Apr 14 21:14:00 CST 2019, time=2019-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1797469, encodeId=2fb41e9746945, content=<a href='/topic/show?id=96eb22906b9' target=_blank style='color:#2F92EE;'>#临床病理#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22906, encryptionId=96eb22906b9, topicName=临床病理)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Sun Oct 14 06:14:00 CST 2018, time=2018-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1790221, encodeId=48ec1e9022142, content=<a href='/topic/show?id=6e4814388e2' target=_blank style='color:#2F92EE;'>#Plos one#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14388, encryptionId=6e4814388e2, topicName=Plos one)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Sat Jun 16 22:14:00 CST 2018, time=2018-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=327106, encodeId=671732e10696, content=和某大型骨干 v 巴基耶夫的现身说法有太多, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/05/ed2bf06fea1e697cb8fe1644bfcec307.jpg, createdBy=73971617491, createdName=小小医森, createdTime=Tue Jun 26 08:39:15 CST 2018, time=2018-06-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326832, encodeId=3de7326832cf, content=感谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/05/ed2bf06fea1e697cb8fe1644bfcec307.jpg, createdBy=73971617491, createdName=小小医森, createdTime=Mon Jun 25 08:07:54 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326597, encodeId=a7e732659efe, content=哈哈哈哈哈哈哈哈好, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/05/ed2bf06fea1e697cb8fe1644bfcec307.jpg, createdBy=73971617491, createdName=小小医森, createdTime=Sun Jun 24 10:50:31 CST 2018, time=2018-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=324342, encodeId=b9ee32434256, content=感谢学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/05/ed2bf06fea1e697cb8fe1644bfcec307.jpg, createdBy=73971617491, createdName=小小医森, createdTime=Fri Jun 15 07:58:18 CST 2018, time=2018-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323993, encodeId=095b323993ab, content=学习学习学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzR8ylhYfiaoAUx2BsaYHVia1IKhG3Cg8CT84rBrn6iaVRkyAibJxBcLEXabOQ5p19vWgDe34ib5ErxNgx/0, createdBy=8a701629084, createdName=jihuaijun1112, createdTime=Thu Jun 14 06:32:02 CST 2018, time=2018-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323988, encodeId=d56132398843, content=哈哈哈哈哈哈哈哈好, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/05/ed2bf06fea1e697cb8fe1644bfcec307.jpg, createdBy=73971617491, createdName=小小医森, createdTime=Thu Jun 14 06:27:31 CST 2018, time=2018-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=323786, encodeId=6aa4323e86d7, content=学习学习学习创新宣传促销, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/05/ed2bf06fea1e697cb8fe1644bfcec307.jpg, createdBy=73971617491, createdName=小小医森, createdTime=Wed Jun 13 08:12:22 CST 2018, time=2018-06-13, status=1, ipAttribution=)]
    2018-06-13 小小医森

    学习学习学习创新宣传促销

    0

相关资讯

NEJM:绝经期前乳腺癌患者辅助内分泌治疗效果研究

研究认为,对于绝经期前乳腺癌患者,依西美坦联合卵巢抑制可获得最佳的长期疾病缓解效果

Radiology:扩散峰度成像放射组学能不能排除乳腺癌的可疑性?

本研究旨在评估乳腺组织成像数据系统(Bi-RADS)4类和5类乳腺组织病变的放射组学模型,这些病变是利用与活检相似的敏感阈值从乳腺组织优化峰度磁共振(MR)成像的病变特征提取得到的。

J Natl Cancer Inst:早期乳腺癌:化疗使用和肿瘤科专家治疗建议的近期趋势

2018年5月,发表在《J Natl Cancer Inst》的一项由美国科学家进行的研究,考察了早期乳腺癌化疗的使用和肿瘤科专家治疗建议的近期趋势。

CLIN CANCER RES:化疗会诱导乳腺癌异常单核细胞增多相关干性

局部晚期或炎性乳腺癌患者接受术前或新辅助治疗正逐渐增加,以期达到更好的手术切除效果和病理学反应。但是,许多乳腺癌治疗后会耐药或复发。CLIN CANCER RES近期发表了一篇文章,研究化疗触发的促进肿瘤干细胞样亚型(CSC)发生及肿瘤复发的系统及局部变化。

NEJM:21基因乳腺癌复发风险评分与化疗

对于21基因乳腺癌复发风险评分11-25分的患者,仅接受内分泌治疗即可实现对疾病的有效控制

Lancet oncol:ABP980,曲妥珠单抗的生物类似物,用于HER2阳性的乳腺癌患者的效果和安全性,与曲妥珠单抗的不相上下

ABP980是曲妥珠单抗的生物类似物,与曲妥珠单抗具有相似的分析、功能和药代动力学。现研究人员在多个国家的97个研究中心开展一随机的、多中心、双盲、活性对照的等效试验,对比ABP980与曲妥珠单抗用于HER2阳性的早期乳腺癌的效果和安全性。招募年满18岁的组织学确诊的HER2阳性的侵袭性早期乳腺癌患者,ECOG表现评分0-1分、计划进行采样手术切除肿瘤以及前哨或腋窝淋巴结清扫和新辅助化疗。经过4个